R&D channel feed – Endpoints News

R&D channel feed

Pfizer ends rollout of Beqvez, putting another dent in hemophilia gene therapy field

3 months ago

Roche no longer wants to be where ‘DNA sequencing goes to die’

3 months ago

In single case, spinal muscular atrophy drug given before birth spared baby of genetic disease symptoms

3 months ago

Can amylin drugs take over from GLP-1s in obesity? Partnerless Zealand thinks so

3 months ago

Ascletis’ obesity pill looks similar to Roche’s drug, early data suggest

3 months ago

Will CRISPR matter?

3 months ago

Supernus’ stock sinks after placebo effect derails mid-stage depression study

3 months ago

Exclusive: CRISPR delivery startup, based on UC Berkeley and UCSF science, shuts down

3 months ago

As part of turnaround, Solid Bio reports promising initial data for Duchenne gene therapy

3 months ago

Arcus touts early kidney cancer data as Gilead declines option

3 months ago

French biotech’s topical pain treatment fails Phase 2 study with overperforming placebo

3 months ago

Lilly’s early bladder cancer data hint at safety edge over J&J’s Balversa

3 months ago

Corbus shares dip on mixed Phase 1 solid tumor data for Nectin-4 ADC

3 months ago

BioNTech vets raise $90M Series A for bispecific I&I startup

3 months ago

Bristol Myers’ Opdualag stumbles in late-stage resected melanoma trial

3 months ago

Labs fear future funding cuts with Trump administration actions in limbo

3 months ago

Agios’ Pyrukynd succeeds in key trial of rare red blood cell disorder in kids

3 months ago

Sanofi faces $250M charge after J&J-partnered vaccine flunks late-stage test

3 months ago

Novo's weight loss drug helps curb some drinking habits, small study shows

3 months ago

Pfizer wins approval in new indication for blood cancer drug Adcetris

3 months ago

AnaptysBio gets a mid-stage win for PD-1 drug in rheumatoid arthritis

3 months ago

AbbVie pens another T cell engager deal, this time with Xilio

3 months ago

Exclusive: Longevity startup targets renegade proteins linked to diabetes and obesity

3 months ago

New CMO Dietmar Berger highlights Gilead’s ‘unique situation’ and its HIV ambitions

3 months ago

First page Previous page 7 8 91011 12 13 Next page Last page